Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers.

  title={Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers.},
  author={Michael S. Okun and Michele Tagliati and Michael Pourfar and Hubert H Fernandez and Ramon L. Rodriguez and Ron L. Alterman and Kelly D. Foote},
  journal={Archives of neurology},
  volume={62 8},
BACKGROUND Since the Food and Drug Administration approved DBS, there has been a surge in the number of centers providing the procedure. There is currently no consensus regarding appropriate screening procedures, necessary training of individuals providing the therapy, the need for an interdisciplinary team, or guidelines for the management of complications. An increasing number of patients come to experienced DBS centers after unsatisfactory results from DBS surgery. An attempt is made herein… 

Figures from this paper

Referring patients for deep brain stimulation: an improving practice.

Compared with findings in prior studies, the quality of DBS referrals has improved and the increase in referral of possible future candidates and poor candidates may reflect greater confidence in the procedure.


An unblinded retrospective chart review of DBS patients with unsatisfactory outcomes who presented for reoperation found that lead placement beyond a 2- to 3-mm window resulted in inadequate clinical benefit, and, in 1 patient, revision improved outcome.

DBS Revision Surgery: Indications and Nuances

This chapter reviews methods for evaluating patients presenting with DBS failure to identify appropriate candidates for various surgical salvage procedures, and presents successful decision-making strategies and surgical techniques for carrying out these operations.

DBS Candidates That Fall Short on a Levodopa Challenge Test: Alternative and Important Indications

Although motor response to levodopa remains the primary selection criteria for DBS candidacy in Parkinson disease, patients who do not meet the 30% threshold and have disabling symptoms may still benefit from DBS.

Deep Brain Stimulation

DBS is an effective surgical treatment for movement disorders with sustained long-term benefits and may be the preferred site of stimulation for dystonia with movement scores typically improved by 75% in patients with primary dySTONia.

The current state of postoperative imaging in the presence of deep brain stimulation electrodes

Although the potential danger imposed by MRI scanning in the presence of electrodes should not be disregarded, the fear of such procedures should not impact patient care, and postoperative MRI scanning is invaluable for proper electrode placement verification and diagnostic applications.

Rescuing Suboptimal Outcomes of Subthalamic Deep Brain Stimulation in Parkinson Disease by Surgical Lead Revision.

Patients with persistent OFFmotor symptoms after STN-DBS should be screened for levodopa-responsiveness, which can serve as a benchmark for best achievable motor benefit.

State of the Art for Deep Brain Stimulation Therapy in Movement Disorders: A Clinical and Technological Perspective

The goal of this review is to describe the current status of DBS in the context of movement disorders, outline the mechanisms of action for DBS, discuss the standard surgical and imaging techniques, and discuss the patient selection and clinical outcomes in each of the movement disorders.

Risks of common complications in deep brain stimulation surgery: management and avoidance.

The authors confirmed that the overall risk of both procedure- and hardware-related adverse events is acceptably low and offered advice on how to avoid the most common complications.

Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report.

This case demonstrates the ineffectiveness of DBS in MSA, even when the patient is responsive to levodopa, and emphasizes the need for diagnostic modalities that can be used to distinguish PD from MSA and other parkinsonian syndromes in which thelevodopa response pattern is typical of PD.

Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies

  • M. OkunJ. Vitek
  • Medicine, Psychology
    Movement disorders : official journal of the Movement Disorder Society
  • 2004
An analysis of the international literature on lesioning for movement disorders was undertaken to review lesion therapy for Parkinson's disease (PD) and other movement disorders and to highlight

Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy

Clinical features and brain MRI in this case were indicative of multiple system atrophy (MSA) and STN DBS is not recommended for patients with MSA.

Development and initial validation of a screening tool for Parkinson disease surgical candidates

The results of this study suggest that the FLASQ-PD may be a useful triage tool for screening PD patients for DBS surgery.

Deep brain stimulation for Parkinson's disease: Patient selection and evaluation

  • A. LangH. Widner
  • Medicine, Psychology
    Movement disorders : official journal of the Movement Disorder Society
  • 2002
This review will discuss the various factors influencing patient selection and summarize the recommended approach to patient assessment by using the Core Assessment Program for Surgical Interventions and Transplantation in Parkinson's Disease (CAPSIT‐PD).

Safety and Risk of Microelectrode Recording in Surgery for Movement Disorders

  • M. Hariz
  • Medicine
    Stereotactic and Functional Neurosurgery
  • 2002
A critical review of the published literature revealed that microelectrode recording techniques do not necessarily improve targeting accuracy or clinical results, compared to techniques using impedance monitoring and macrostimulation.

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

The pathological findings in 100 patients diagnosed prospectively by a group of consultant neurologists as having idiopathic Parkinson's disease are reported, and these observations call into question current concepts of Parkinson's Disease as a single distinct morbid entity.

Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.

This study confirms features suggested to predict these disorders, except for the early presence of postural imbalance, which is not indicative of either disorder.

Consensus statement on the diagnosis of multiple system atrophy

[Diagnostic criteria of parkinsonian syndromes].

  • F. Tison
  • Medicine, Psychology
    Revue neurologique
  • 2003
Any atypical sign, also commonly known as "red flags", should make the clinician aware of an alternative diagnosis: multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration and parkinsonism associated with dementia such as dementia with diffuse Lewy body disease.